An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

MULPLETA®

Drug Information Related Patent

Hold Company

SHIONOGI INC

Learn More

Dosage and Administration

TABLET;ORAL

Specification

3MG

Indication

MULPLETA® is used for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo surgery.

Use

Instructions for Use

API

LUSUTROMBOPAG

API Structure

We Supply

LUSUTROMBOPAG

Note:

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
7601746	2024/9/5
8530668	2030/1/21
8889722	2028/7/29
9427402	2031/9/29

API Patent

Patent No	Expiration Date
7601746	2024/9/5

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION